Global Antibiotics Market 2017-2021


◆タイトル:Global Antibiotics Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
◆産業分野:Healthcare and Life Sciences
Single User(1名利用)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About Antibiotics
An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term “antibiotic” was originally coined to refer to any compound of microbial origin that is antagonistic to the growth of the microbe. Antibiotics act via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis.

Technavio’s analysts forecast the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global antibiotics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• GlaxoSmithKline
• Merck
• Pfizer

[Other prominent vendors]
• Abbott
• Achaogen
• Actelion Pharmaceuticals
• AmpliPhi Biosciences
• Aspen Pharmacare
• Astellas Pharma
• AstraZeneca
• Aurobindo Pharma
• Baxter
• Basilea Pharmaceutica
• Bayer HealthCare
• Biocon
• Bristol-Myers Squibb
• Cempra
• Cipher Pharmaceuticals
• CordenPharma
• Chiesi Farmaceutici
• Eli Lilly
• Exoxemis
• F. Hoffmann-La Roche
• Flynn Pharma
• Incepta Pharmaceuticals
• InSite Vision
• Insmed
• Johnson & Johnson
• Humanigen
• Kyorin Pharmaceutical
• Lupin Pharmaceuticals
• Lytix Biopharma
• Melinta Therapeutics
• Mylan
• Nektar
• Orchid Pharma
• Par Pharmaceutical
• Paratek Pharmaceuticals
• Pernix Therapeutics
• PTC Therapeutics
• RedHill
• Sagent Pharmaceuticals
• Sanofi
• Shionogi
• Starpharma
• Sun Pharmaceutical
• Symbiomix
• Takeda Pharmaceutical
• Tetraphase Pharmaceuticals
• Theravance Biopharma
• The Medicines Company
• Valneva
• Wockhardt

[Market driver]
• Rising prevalence of infectious diseases
• For a full, detailed list, view our report

[Market challenge]
• Development of antibiotic-resistant strains
• For a full, detailed list, view our report

[Market trend]
• Strategic alliances and mergers and acquisitions (M&A)
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Antibiotics: An overview
• Introduction
• Mechanism of action of antibiotics
• General principles for the use of antibiotics
• Clinical use of antibiotics
• Epidemiology of infections
• Application of antibiotics

PART 06: Veterinary drug approval process
• Animal antibiotics
• NADAs and supplements
• ANADAs and supplements

PART 07: Antibiotic resistance: An overview
• Cause of antibiotic resistance
• Development of antibiotic resistance
• Spread of antibiotic resistance
• Initiatives to facilitate antibiotic development

PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 09: Pipeline landscape
• Gepotidacin
• MK-3415A
• Amikacin Inhale
• Carbavance
• Eravacycline
• Plazomicin
• Delafloxacin
• Solithromycin
• Cadazolid
• Ozenoxacin

PART 10: Market segmentation by chemical class
• Beta-lactams
• Macrolides
• Quinolones
• Others

PART 11: Market segmentation by drug origin
• Natural
• Semisynthetic
• Synthetic

PART 12: Market segmentation by mechanism of action
• Bacteriostatic
• Bactericidal

PART 13: Market segmentation by application
• Antibiotics for human use
• Antibiotics for veterinary use

PART 14: Market segmentation by spectrum
• Broad-spectrum antibiotics
• Narrow-spectrum antibiotics

PART 15: Geographical segmentation
• Market overview
• Antibiotics market in APAC
• Antibiotics market in Americas
• Antibiotics market in EMEA

PART 16: Decision framework

PART 17: Drivers and challenges
• Market drivers
• Market challenges

PART 18: Market trends
• Strategic alliances and mergers and acquisitions (M&A)
• Patient assistance programs (PAPs)
• Increased federal and institutional funding on antibiotic research

PART 19: Vendor landscape
• Competitive scenario

PART 20: Key vendor analysis
• Allergan
• GlaxoSmithKline
• Merck
• Pfizer1
• Other prominent vendors

PART 21: Appendix
• List of abbreviations

[List of Exhibits] 
Exhibit 01: Overview of mechanism of action of antibiotics
Exhibit 02: Mechanism of action of antibiotics
Exhibit 03: General principles involved in the use of antibiotics
Exhibit 04: Clinical use of antibiotics for treatment of various common infections
Exhibit 05: Types of HAIs 2016
Exhibit 06: Causes of antibiotic resistance
Exhibit 07: Transfer of antibiotic-resistant strain
Exhibit 08: Development of antibiotic resistance
Exhibit 09: Spread of antibiotic resistance
Exhibit 10: Antibiotic resistance scenario in the US
Exhibit 11: Initiatives to facilitate antibiotic development
Exhibit 12: Global antibiotics market snapshot
Exhibit 13: Global antibiotics market revenue 2016-2021 ($ millions)
Exhibit 14: Opportunity analysis of global antibiotics market
Exhibit 15: Five forces analysis
Exhibit 16: Pipeline landscape of global antibiotics market 2016
Exhibit 17: Key clinical trials
Exhibit 18: Segmentation of global antibiotics market by chemical class 2016
Exhibit 19: Segmentation of global antibiotics market share by chemical class 2016
Exhibit 20: Cephalosporin segmentation by generation of drugs
Exhibit 21: Segmentation Global antibiotics market by drug origin 2016
Exhibit 22: Segmentation of global antibiotics market by mechanism of action 2016
Exhibit 23: Segmentation of global antibiotics market by application 2016
Exhibit 24: Segmentation of global antibiotics market by spectrum 2016
Exhibit 25: Global antibiotics market share by spectrum 2016
Exhibit 26: Global broad-spectrum antibiotics market 2016-2021 ($ millions)
Exhibit 27: Global narrow-spectrum antibiotics market 2016-2021 ($ millions)
Exhibit 28: Segmentation of global antibiotics market share by geography 2016 and 2021
Exhibit 29: Segmentation of global antibiotics market revenue by geography 2016-2021
Exhibit 30: Segmentation of global antibiotics market share by geography 2016-2021 (%)
Exhibit 31: Antibiotics market scenario in different regions
Exhibit 32: Market scenario in APAC
Exhibit 33: Antibiotics market in APAC 2016-2021 ($ millions)
Exhibit 34: Market scenario in Americas
Exhibit 35: Antibiotics market in Americas 2016-2021 ($ millions)
Exhibit 36: Legislation regulating antibiotic use in US
Exhibit 37: Market scenario in EMEA
Exhibit 38: Antibiotics market in EMEA 2016-2021 ($ millions)
Exhibit 39: Antibiotic-resistant strains according to the period of development of resistance
Exhibit 40: Antibiotic drug approvals versus time interval
Exhibit 41: Competitive structure analysis of global antibiotics market 2016
Exhibit 42: Allergan: Key highlights
Exhibit 43: Allergan: Strength assessment
Exhibit 44: Allergan: Strategy assessment
Exhibit 45: Allergan: Opportunity assessment
Exhibit 46: GlaxoSmithKline: Key highlights
Exhibit 47: GlaxoSmithKline: Strength assessment
Exhibit 48: GlaxoSmithKline: Strategy assessment
Exhibit 49: GlaxoSmithKline: Opportunity assessment
Exhibit 50: Merck: Key highlights
Exhibit 51: Merck: Strength assessment
Exhibit 52: Merck: Strategy assessment
Exhibit 53: Merck: Opportunity assessment
Exhibit 54: Pfizer: Key highlight
Exhibit 55: Pfizer: Strength assessment
Exhibit 56: Pfizer: Strategy assessment
Exhibit 57: Pfizer: Opportunity assessment


Allergan, GlaxoSmithKline, Merck, Pfizer, Abbott, Achaogen, Actelion Pharmaceuticals, AmpliPhi Biosciences, Aspen Pharmacare, Astellas Pharma, AstraZeneca, Aurobindo Pharma, Baxter, Basilea Pharmaceutica, Bayer HealthCare, Biocon, Bristol-Myers Squibb, Cempra, Cipher Pharmaceuticals, CordenPharma, Chiesi Farmaceutici, Eli Lilly, Exoxemis, F. Hoffmann-La Roche, Flynn Pharma, Incepta Pharmaceuticals, InSite Vision, Insmed, Johnson & Johnson, Humanigen, Kyorin Pharmaceutical, Lupin Pharmaceuticals, Lytix Biopharma, Melinta Therapeutics, Mylan, Nektar, Orchid Pharma, Par Pharmaceutical, Paratek Pharmaceuticals, Pernix Therapeutics, PTC Therapeutics, RedHill, Sagent Pharmaceuticals, Sanofi, Shionogi, Starpharma, Sun Pharmaceutical, Symbiomix, Takeda Pharmaceutical, Tetraphase Pharmaceuticals, Theravance Biopharma, The Medicines Company, Valneva, and Wockhardt.

★調査レポート[抗生物質の世界市場2017-2021:天然、半合成、合成] (Global Antibiotics Market 2017-2021 / IRTNTR14623)販売に関する免責事項
[抗生物質の世界市場2017-2021:天然、半合成、合成] (Global Antibiotics Market 2017-2021 / IRTNTR14623)についてEメールでお問い合わせ